Subscribe to EDOM TECH Newsletter
ams OSRAM
2020/08/25
ams provides sensor technology for medical technology startup midge medical to develop rapid test device for COVID-19 (SARS-CoV-2)
- Rapid test results will be available in as little as 15 minutes
- Miniaturization of genetic amplification technique enables implementation of effective test strategies at a reduced cost, both at home and in professional healthcare environments
- ams AS7341L spectral sensor allows reliable spectrally resolved read out of virus particles
ams (SIX: AMS), a leading worldwide supplier of high performance sensor solutions, provides the latest sensor technology to midge medical, a German medical technology startup from Berlin, to develop a disruptive technology for science-backed rapid genetic and blood testing in a home and professional healthcare environment at a lower cost. midge medical’s current focus is on developing a pocket-sized COVID-19 (SARS-CoV-2) genetic test. Test results can be read-out using a smartphone in as little as 15 minutes. ams and midge medical’s collaboration aims to provide a technology with the potential to move the current market forward.
A specifically developed sensor system based on the ams AS7341L spectral sensor solution allows spectrally resolved read out of amplified COVID-19 (SARS-CoV-2) virus particles, strengthening ams’ position in delivering high-quality consumer health diagnostics.
Helping fight the COVID-19 (SARS-CoV-2) pandemic
A promising cooperation
“We are pleased to collaborate with ams as a globally known strong partner to bring this low cost type of test to the market. By enabling broad and frequent testing, even in the absence of immunization, going back to an almost normal life will be possible again,” added Michael Diebold, CEO at midge medical.
For more information on the ams AS7341L spectral sensor, please visit ams.com. (Source: ams website)
